In this study, we explored the relationship between CLR, LAR, and overall survival in AM patients, and further examined how these blood markers correlate with TLS status and immune cell profiles in the tumor microenvironment. This evidence concerns the gene DCLK3 and acute myeloblastic leukemia with maturation.